Latest Ratios: P/E Ratio -8.8x · EV/EBITDA 100.8x · ROE -14.7%. (2005–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.1B | $661M | $605M | $1.5B | $1.7B | $1.6B | $456M | $588M | $541M | $847M | $1.1B |
| Enterprise Value | $1.4B | $987M | $1.1B | $1.8B | $2.0B | $2.0B | $813M | $961M | $1.2B | $1.9B | $1.9B |
| P/E Ratio → | -8.78 | — | — | — | — | — | — | — | 33.62 | 11.46 | 99.46 |
| P/S Ratio | 0.53 | 0.32 | 0.25 | 0.45 | 0.46 | 0.57 | 0.24 | 0.24 | 0.14 | 0.24 | 0.31 |
| P/B Ratio | 1.38 | 0.86 | 0.69 | 1.50 | 1.60 | 1.47 | 0.59 | 0.68 | 0.51 | 0.80 | 1.10 |
| P/FCF | 17.17 | 10.26 | — | — | — | — | — | — | — | — | 43.29 |
| P/OCF | 10.89 | 6.51 | — | 26.32 | 24.30 | 381.92 | 4.61 | — | 13.88 | — | 12.94 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.47 | 0.44 | 0.55 | 0.54 | 0.70 | 0.42 | 0.40 | 0.31 | 0.54 | 0.55 |
| EV / EBITDA | 100.79 | 69.48 | 25.07 | 49.37 | — | 16.90 | — | — | 6.27 | 14.81 | 10.68 |
| EV / EBIT | — | — | — | — | — | 82.21 | — | — | — | 41.30 | 20.83 |
| EV / FCF | — | 15.32 | — | — | — | — | — | — | — | — | 75.71 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 1.8% | 1.8% | 5.3% | 5.0% | 3.1% | 6.3% | 4.4% | 1.3% | 5.6% | 8.2% | 9.2% |
| Operating Margin | -4.0% | -4.0% | -1.9% | -1.9% | -2.7% | 0.9% | -6.4% | -5.9% | 2.3% | 0.7% | 2.7% |
| Net Profit Margin | -5.8% | -5.8% | -3.4% | -2.8% | -3.5% | -2.3% | -5.7% | -6.9% | 0.4% | 1.7% | 0.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -14.7% | -14.7% | -8.8% | -9.1% | -11.8% | -7.0% | -13.2% | -17.3% | 1.5% | 6.0% | 1.1% |
| ROA | -7.2% | -7.2% | -4.4% | -4.6% | -5.9% | -3.5% | -6.6% | -8.5% | 0.6% | 2.3% | 0.5% |
| ROIC | -5.2% | -5.2% | -2.7% | -3.5% | -5.3% | 1.5% | -7.8% | -7.3% | 3.5% | 0.9% | 4.9% |
| ROCE | -6.2% | -6.2% | -3.2% | -3.9% | -6.0% | 1.8% | -10.7% | -11.2% | 5.5% | 1.3% | 5.4% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.66 | 0.66 | 0.74 | 0.68 | 0.67 | 0.72 | 0.76 | 0.72 | 0.84 | 1.29 | 1.13 |
| Debt / EBITDA | 35.77 | 35.77 | 15.06 | 18.45 | — | 6.72 | — | — | 4.74 | 10.38 | 6.30 |
| Net Debt / Equity | — | 0.42 | 0.54 | 0.33 | 0.25 | 0.33 | 0.46 | 0.43 | 0.60 | 1.03 | 0.82 |
| Net Debt / EBITDA | 22.94 | 22.94 | 11.04 | 8.92 | — | 3.09 | — | — | 3.40 | 8.35 | 4.57 |
| Debt / FCF | — | 5.06 | — | — | — | — | — | — | — | — | 32.43 |
| Interest Coverage | -0.88 | -0.88 | -1.15 | -1.18 | -2.02 | 0.36 | -3.03 | -3.30 | -0.64 | 0.56 | 1.74 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.79 | 1.79 | 1.48 | 1.90 | 1.91 | 2.37 | 1.42 | 1.23 | 1.45 | 1.36 | 1.68 |
| Quick Ratio | 1.24 | 1.24 | 0.89 | 1.34 | 1.33 | 1.80 | 0.82 | 0.77 | 0.56 | 0.56 | 0.97 |
| Cash Ratio | 0.68 | 0.68 | 0.45 | 0.91 | 0.91 | 1.17 | 0.52 | 0.45 | 0.30 | 0.30 | 0.51 |
| Asset Turnover | — | 1.33 | 1.38 | 1.70 | 1.73 | 1.31 | 1.22 | 1.42 | 1.74 | 1.30 | 1.36 |
| Inventory Turnover | 13.86 | 13.86 | 10.24 | 14.51 | 12.73 | 9.89 | 6.82 | 9.43 | 4.96 | 4.64 | 7.33 |
| Days Sales Outstanding | — | 12.98 | 14.09 | 10.55 | 10.95 | 15.61 | 10.67 | 17.12 | 9.54 | 15.99 | 15.78 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | 0.9% | 1.5% | — | 0.6% | 2.1% | 5.4% | 7.6% | 4.7% | 3.5% |
| Payout Ratio | — | — | — | — | — | — | — | — | 259.2% | 64.5% | 349.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | 3.0% | 8.7% | 1.0% |
| FCF Yield | 5.8% | 9.7% | — | — | — | — | — | — | — | — | 2.3% |
| Buyback Yield | 2.7% | 4.5% | 0.8% | 0.6% | 0.0% | 0.0% | 2.5% | 10.5% | 0.6% | 0.8% | 0.6% |
| Total Shareholder Yield | 2.7% | 4.5% | 1.6% | 2.1% | 0.0% | 0.6% | 4.6% | 15.9% | 8.2% | 5.4% | 4.0% |
| Shares Outstanding | — | $67M | $64M | $59M | $56M | $47M | $35M | $38M | $41M | $50M | $39M |
Commodity crush spread volatility
As reported in financial statements, GPRE's EV/EBITDA multiple of 97.29 suggests that the market is pricing the company as a distressed turnaround play rather than a stable specialty chemical producer, with forward multiples indicating significant skepticism regarding the company's ability to achieve consistent, high-margin profitability in the near term.
The extreme disparity between current and forward EV/EBITDA multiples implies that investors are banking on a sharp recovery in operational performance that has yet to materialize. Given the negative P/E and the lack of a PEG ratio, the current valuation appears to be driven more by speculative interest in the biorefinery pivot than by fundamental earnings power.
Based on the provided quarterly data, GPRE's ROIC has struggled to maintain positive territory, frequently dipping into negative values such as the -3.5% reported in 2025Q1, which highlights the company's difficulty in generating adequate returns on the capital invested in its ongoing biorefinery technological upgrades.
The inconsistent ROIC trend suggests that the company's capital-intensive strategy is not yet yielding the expected efficiency gains. Investors should monitor whether the recent shift toward specialty ingredients can eventually drive a sustained improvement in returns, or if the high cost of asset retrofitting will continue to suppress capital productivity.
According to historical financial data, GPRE's cash conversion cycle has fluctuated significantly, ranging from 22 to 34 days over the last ten quarters, which indicates that the company's ability to manage its inventory and receivables is highly sensitive to the underlying volatility of the agricultural commodity markets.
The variability in the cash conversion cycle suggests that GPRE lacks the operational leverage to dictate terms to its suppliers or customers effectively. This inefficiency forces the company to maintain a larger liquidity buffer than would be required in a more stable, less commodity-dependent business model.
As evidenced by the company's reported figures, GPRE's debt-to-equity ratio has oscillated between 0.56 and 0.82, suggesting that management utilizes debt as a tactical tool to navigate the inherent cyclicality of the ethanol crush spread rather than maintaining a static, long-term capital structure for the firm.
While the current debt levels appear manageable, the inconsistent interest coverage ratios, which have frequently dipped into negative territory, warrant further investigation into the company's refinancing risk. The reliance on debt to bridge operational gaps during downturns leaves the balance sheet vulnerable to prolonged periods of unfavorable commodity pricing.
The P/E ratio is frequently misapplied to GPRE, as the company's earnings are heavily distorted by non-cash derivative hedging activities and the cyclical nature of the ethanol crush spread, which obscures the underlying operational reality of its transition toward a specialty ingredient and protein-focused business model.
Investors should prioritize adjusted EBITDA or cash-based metrics over P/E, as the latter fails to account for the significant capital expenditures and non-recurring items inherent in the company's biorefinery pivot. Relying on P/E in this context may lead to an inaccurate assessment of the company's true earning power and long-term value creation potential.
Includes 30+ ratios · 21 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GPRE stock.
Green Plains Inc.'s current P/E ratio is -8.8x. The historical average is 45.0x.
Green Plains Inc.'s current EV/EBITDA is 100.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.5x.
Green Plains Inc.'s return on equity (ROE) is -14.7%. The historical average is -1.1%.
Based on historical data, Green Plains Inc. is trading at a P/E of -8.8x. Compare with industry peers and growth rates for a complete picture.
Green Plains Inc. has 1.8% gross margin and -4.0% operating margin.
Green Plains Inc.'s Debt/EBITDA ratio is 35.8x, indicating high leverage. A ratio above 4x may signal elevated financial risk.